Neoadjuvant Docetaxel Plus Cisplatin and 5-fluorouracil (TPF) Followed by Concomitant Chemoradiotherapy and Chemoradiotherapy Alone in Locally Advanced Squamous Cell Carcinoma of the Head and Neck Patients (SCCHNS)

PHASE2CompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

February 29, 2008

Conditions
Head and Neck Neoplasms
Interventions
DRUG

Docetaxel, cisplatin and 5-FU treatment followed by concomitant cisplatin, 5-FU and radiotherapy

DRUG

Concomitant cisplatin, 5-FU and radiotherapy

Trial Locations (1)

Unknown

Sanofi-Aventis, Milan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY